StellaLife Innovator Series: Dr. Dale Bredesen on Oral Health and Alzheimer’s

In a recent StellaLife Innovator Series interview, host Liz Landry spoke with Dr. Dale Bredesen about how his ReCODE Protocol addresses cognitive decline by targeting multiple contributors rather than a single cause. He explained that factors such as chronic inflammation, infections, toxins, reduced blood flow, and sleep apnea all play a role in Alzheimer’s disease and other dementias. By identifying and treating these issues in combination, clinical trials have shown measurable improvements in patients experiencing cognitive decline.

Much of the conversation focused on the strong connection between oral health and brain health. Bredesen noted that oral pathogens linked to gum disease are often found in the brains of Alzheimer’s patients, making dental evaluation and treatment essential. He described how tools like cone beam imaging, salivary diagnostics, and the use of oral probiotics and rinses, including those from StellaLife, can help reduce risk. Both Landry and Bredesen emphasized that closer collaboration between dental professionals and physicians is key to improving outcomes and preventing decline.

Watch Here: